EUVIMEDEUVIMED entdecken
Crossref

Identification of BRAF Inhibitor Resistance–associated lncRNAs Using Genome-scale CRISPR-Cas9 Transcriptional Activation Screening

Xuan Wen, Min Han, Masaki Hosoya, Rika Toshima, Mai Onishi, Tomoaki Fujii, Shigeo Yamaguchi, Shunsuke Kato

Anticancer Research · 2024

DOI: 10.21873/anticanres.17042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Xuan Wen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, RNA, Long Noncoding, Drug Resistance, Neoplasm, CRISPR-Cas Systems. Die Arbeit wurde bisher 9-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafRNA, Long NoncodingDrug Resistance, NeoplasmCRISPR-Cas SystemsMelanomaTranscriptional ActivationProtein Kinase InhibitorsHumansCell Line, TumorGene Expression Regulation, NeoplasticImidazolesMutationOximesRNA, MessengerGene Regulatory Networks

Stichwörter der Autor:innen

BRAF inhibitordrug resistancelncRNAmelanoma

Substanzen

Proto-Oncogene Proteins B-rafRNA, Long NoncodingBRAF protein, humanProtein Kinase InhibitorsdabrafenibImidazolesOximesRNA, Messenger

Autor:innen und Institutionen

  • Department of Clinical Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Department of Clinical Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan katoshun@juntendo.ac.jp.

Zitieren

APA

Wen, X., Han, M., Hosoya, M., Toshima, R., Onishi, M., Fujii, T., Yamaguchi, S., & Kato, S. (2024). Identification of BRAF Inhibitor Resistance–associated lncRNAs Using Genome-scale CRISPR-Cas9 Transcriptional Activation Screening. Anticancer Research. https://doi.org/10.21873/anticanres.17042

Vancouver

Wen X, Han M, Hosoya M, Toshima R, Onishi M, Fujii T, et al. Identification of BRAF Inhibitor Resistance–associated lncRNAs Using Genome-scale CRISPR-Cas9 Transcriptional Activation Screening. Anticancer Research. 2024. doi:10.21873/anticanres.17042

BibTeX
@article{Wen2024,
  author = {Wen, Xuan and Han, Min and Hosoya, Masaki and Toshima, Rika and Onishi, Mai and Fujii, Tomoaki and Yamaguchi, Shigeo and Kato, Shunsuke},
  title = {Identification of BRAF Inhibitor Resistance–associated lncRNAs Using Genome-scale CRISPR-Cas9 Transcriptional Activation Screening},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17042}
}
Kostenlos starten →